Exprivia SpA
MIL:XPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Exprivia SpA
MIL:XPR
|
IT |
|
Assicurazioni Generali SpA
F:ASG
|
IT |
|
Batulicin Nusantara Maritim Tbk PT
IDX:BESS
|
ID |
|
Tekfen Holding AS
IST:TKFEN.E
|
TR |
|
Almirall SA
F:E2Z
|
ES |
|
I
|
Industrial and Commercial Bank of China Ltd
XBER:ICK
|
CN |
|
P
|
Philip Morris CR as
PSE:TABAK
|
CZ |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XPR's stock price target?
Not Available
XPR does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Exprivia SpA?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 1 year is 0%.
What is the Operating Income forecast for Exprivia SpA?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 1 year is 4%.